It has been found that there are significant immunosuppression and immune disorders in patients with malignant tumors such as lung cancer, esophageal cancer, gastric cancer, colon cancer and gastric cancer, with decreased levels of CD3 + T cells, CD4 + T cells, CD8 + T cells, NK cells and other immune effector cells3,4. The gene discussed is CD4; the disease is lung cancer.